Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Ambrose

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|April 24, 2003
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST programP G Ambrose, S M Bhavnani, R N Jones
The Annals of Pharmacotherapy|September 1, 1995
Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDSM J Garvey, P G Ambrose, J L Ulmer
Pediatric Annals|December 16, 1997
On patient compliance with medication dosesP G Ambrose, M J Garvey, B Gunderson, et al.
Connecticut Medicine|May 1, 1997
New generations of quinolones: with particular attention to levofloxacinP G Ambrose, R C Owens, R Quintiliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditisS M Bhavnani, A Prakhya, J P Hammel, et al.
Connecticut Medicine|May 9, 1998
Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenemM A Richerson, P G Ambrose, R Quintiliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2001
Fluoroquinolone pharmacodynamicsG L Drusano, S L Preston, R C Owens, et al.
Clinical Drug Investigation|March 29, 2008
Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusionC A Owens, P G Ambrose, R Quintiliani, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|April 24, 2003
Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: report from the ARREST programP G Ambrose, S M Bhavnani, R N Jones
The Annals of Pharmacotherapy|September 1, 1995
Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDSM J Garvey, P G Ambrose, J L Ulmer
Pediatric Annals|December 16, 1997
On patient compliance with medication dosesP G Ambrose, M J Garvey, B Gunderson, et al.
Connecticut Medicine|May 1, 1997
New generations of quinolones: with particular attention to levofloxacinP G Ambrose, R C Owens, R Quintiliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2009
Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditisS M Bhavnani, A Prakhya, J P Hammel, et al.
Connecticut Medicine|May 9, 1998
Formulary review of the carbapenems: comparison of imipenem/cilastatin and meropenemM A Richerson, P G Ambrose, R Quintiliani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2001
Fluoroquinolone pharmacodynamicsG L Drusano, S L Preston, R C Owens, et al.
Clinical Drug Investigation|March 29, 2008
Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusionC A Owens, P G Ambrose, R Quintiliani, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2009
Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adultsC M Rubino, S M Bhavnani, P G Ambrose, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2015
Population pharmacokinetic analysis for a single 1,200-milligram dose of oritavancin using data from two pivotal phase 3 clinical trialsC M Rubino, S M Bhavnani, G Moeck, et al.
Pageof 5